Affiliations 

  • 1 Orthopaedic and Traumatology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, MYS
  • 2 Orthopaedics, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, MYS
  • 3 Orthopaedic, Universiti Sains Malaysia (USM), Kota Bharu, MYS
  • 4 Orthopaedic and Traumatology, Fakulti Perubatan, Universiti Kebangsaan Malaysia, Kuala Lumpur, MYS
Cureus, 2023 Aug;15(8):e42869.
PMID: 37664329 DOI: 10.7759/cureus.42869

Abstract

Sclerosing/spindle cell rhabdomyosarcoma (s-scRMS) is a rare variant of striated muscle tumours. It has been recognised as an individual entity, the fourth subtype of rhabdomyosarcoma in the latest WHO classification. In the paediatric population, it occurs more commonly in the paratesticular area, whereas in adults, it occurs more commonly in the head and neck region. It has distinctive characteristics in terms of its histopathological and immunochemistry findings, which help in accurate diagnosis. The mainstay of treatment is a multimodal approach, i.e., surgery, chemotherapy, and radiation therapy. However, no standard care is still being established internationally for adult cases. In adults, this tumour has a poorer prognosis as compared to children. We describe a patient with s-scRMS of the lower limb who has undergone wide local resection of the tumour with surgical reconstruction of the distal tibiofibular joint with autograft and its two-year outcome.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.